Sven Rottenberg
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
- Metal complexes synthesis and properties
- Molecular Biology top 1%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Cancer therapeutics and mechanisms
Papers in
-
- DNA Repair Mechanisms 36
- CRISPR and Genetic Engineering 19
- Oncology 46
- PARP inhibition in cancer therapy 30
- Drug Transport and Resistance Mechanisms 7
- Cancer Cells and Metastasis 6
- Co-authors
- Jos Jonkers (39 shared papers)Piet Borst (19 shared papers)Carmen A. Widmer (3 shared papers)Paola Perego (1 shared paper)Janneke E. Jaspers (12 shared papers)Ariena Kersbergen (12 shared papers)Anders O.H. Nygren (4 shared papers)Serge A.L. Zander (5 shared papers)
- Journals
- Cancer Research (7 papers)Drug Resistance Updates (5 papers)Proceedings of the National Academy of Sciences (4 papers)Nature Communications (4 papers)Cell Cycle (3 papers)
- Partner nations
- SwitzerlandNetherlandsUnited Kingdom
In The Last Decade
Sven Rottenberg
94 papers receiving 6.5k citations
Sven Rottenberg's Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 3.5k
- Molecular Biology 3.9k
- Cancer Research 744
- Parasitology 211
- Immunology 643
Countries citing papers authored by Sven Rottenberg
This map shows the geographic impact of Sven Rottenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Rottenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Rottenberg more than expected).
Fields of papers citing papers by Sven Rottenberg
This network shows the impact of papers produced by Sven Rottenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Rottenberg. The network helps show where Sven Rottenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Sven Rottenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs Hit paper breakdown → | 2008 | 771 |
| 2 | The rediscovery of platinum-based cancer therapy Hit paper breakdown → | 2020 | 699 |
| 3 | PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer Hit paper breakdown → | 2019 | 497 |
| 4 | 2012 | 393 | |
| 5 | 2013 | 317 | |
| 6 | 2017 | 261 | |
| 7 | 2018 | 228 | |
| 8 | 2007 | 220 | |
| 9 | 2015 | 211 | |
| 10 | 2011 | 202 | |
| 11 | 2008 | 171 | |
| 12 | 2001 | 143 | |
| 13 | 2015 | 121 | |
| 14 | 2002 | 118 | |
| 15 | 2016 | 117 | |
| 16 | 2018 | 105 | |
| 17 | 2017 | 99 | |
| 18 | 2015 | 98 | |
| 19 | 2017 | 89 | |
| 20 | 2018 | 86 |
About Sven Rottenberg
Sven Rottenberg is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Pulmonary and Respiratory Medicine, having authored 98 papers that have together received 6.5k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (36 papers), PARP inhibition in cancer therapy (30 papers), CRISPR and Genetic Engineering (19 papers), Cancer Genomics and Diagnostics (9 papers), Veterinary Oncology Research (7 papers), BRCA gene mutations in cancer (7 papers), Drug Transport and Resistance Mechanisms (7 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Oncology (3.5k citations), Molecular Biology (3.9k citations), Cancer Research (744 citations), Parasitology (211 citations) and Immunology (643 citations). Sven Rottenberg has collaborated with scholars based in Switzerland, Netherlands and United Kingdom. Frequent co-authors include Jos Jonkers, Piet Borst, Carmen A. Widmer, Paola Perego, Janneke E. Jaspers, Ariena Kersbergen, Anders O.H. Nygren, Serge A.L. Zander, Ewa Gogola and Mark J. O’Connor. Their work appears in journals such as Cancer Research, Drug Resistance Updates, Proceedings of the National Academy of Sciences, Nature Communications and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.